HIV/AIDS

Faculty projects range from protecting incarcerated people to advocacy on behalf of renters and support for people with substance use issues.

At the new research park, the California Institute for Immunology and Immunotherapy at UCLA is poised to enter a new era of biomedical breakthroughs.

The research, funded by a National Institute of Mental Health grant, was led by the UCLA School of Dentistry’s Honghu Liu.

Changes at the DNA level can accelerate aging by nearly five years, UCLA researchers and their colleagues report.

The findings suggest that a drug used to treat HIV-related memory loss could combat cognitive decline in middle-aged people.

The Center for AIDS Research will form new partnerships with community groups across Los Angeles and in other nations.

The new federal funding will support a research agenda aimed at reducing HIV transmission across Southern California, the nation and the world.

Dr. Yvonne Bryson, a pediatric infectious disease expert, led the multicenter study.

The study, which used mice, could point toward a method for clearing the virus from people who would otherwise depend on medication.

The substance, Tg6F, contains anti-inflammatory and antioxidant peptides.

Forty years ago, when a UCLA physician published a three-page report first identifying the disease that would become known as AIDS, few imagined the devastating toll that would follow.

UCLA’s Brad Sears has observed how the current pandemic has been shaped by what we did and did not learn in the past 40 years.

Though medical treatment has progressed, laws that discriminate against people based their HIV-positive status remain on the books across the United States.

The tennis icon spent his life fighting for the oppressed. A new oral history collection tells his story.

NIH-funded grants will aid interventions that improve antiretroviral medication usage.

For the first time there was a showcase dedicated to community-engaged research.

Research brief: A UCLA team has demonstrated that altering a key molecule used in the therapy yields superior and longer-lasting results in mouse models.

The grant comes from the National Institutes of Health to the UCLA branch of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network.

Research brief: Even successfully treated HIV-infected adults are at increased of many diseases more commonly associated with aging.

Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.

Sociologist Victor Agadjanian has worked as a Portuguese-Russian interpreter for Soviet medical missions in Africa and even underwent yearlong training as a witch doctor in Mozambique.

“Through Positive Eyes,” which runs Sept. 15 through Feb. 16, 2020, aims to help end the stigma around HIV/AIDS and empower people who are living with the virus.

In just 100 years, UCLA has grown into a world-class center of learning, research and health care.

The study highlights the importance of screening for congenital cytomegalovirus infection as part of routine care for HIV-exposed infants.

The new work will continue a study that began in 2013 with a $7 million grant from the National Institute on Drug Abuse.